서브이미지
HOME > 자료실 > 문헌자료

문헌자료

ㆍ 제목 Who owns CRISPR-Cas9 in Europe
ㆍ 조회수 424 ㆍ 등록일시 2017-01-02 15:26:46
ㆍ 작성자 관리자
ㆍ 첨부파일

 발행년

 2014

 구분

 국외학술지

 학술지명

 Nature Biotechnology

 관련링크

 http://www.nature.com/nbt/journal/v32/n12/abs/nbt.3086.html

 

 

 

Who owns CRISPR-Cas9 in Europe

 

  • 저자명

Andras Kupecz

  • 학술지명

Nature Biotechnology

  • 권호사항

Vol. 32,

  • 발행처

Nature

  • 자료유형

국외학술지

  • 수록면

1194-1196

  • 언어

English

  • 발행년도

2014. 12

 

 

  • Abstract

Recent developments in the prosecution of the CRISPR-Cas9 patent in Europe highlight the differences between the intellectual property regimes of Europe and the United States. The evolution of the clustered, regularly interspaced, short palindromic repeats (CRISPR)CRISPR-associated protein 9 (Cas9) system (CRISPR-Cas9) as a genome editing tool has undoubtedly been one of the hottest developments in biotech over the last few years.

 

 

 

 

 

ㆍ 이전글 The scope of patent protection for gene technology in China
ㆍ 다음글 우리 특허법상 '발명'의 개념에 관한 고찰 / A study on the Definition for Invention in the Korean Patent Act